THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM

Citation
S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
Citations number
26
Categorie Soggetti
Hematology,"Cardiac & Cardiovascular System","Peripheal Vascular Diseas
Journal title
ISSN journal
03406245
Volume
75
Issue
4
Year of publication
1996
Pages
607 - 611
Database
ISI
SICI code
0340-6245(1996)75:4<607:TSOHFT>2.0.ZU;2-Y
Abstract
An impaired fibrinolytic function has been described in several case-c ontrol studies of patients with venous thromboembolism (VTE). In the p resent study the correlations between some fibrinolytic compounds and future recurrent VTE were investigated. Blood samples for analysis of tissue-type plasminogen activator (t-PA) antigen before and after 10 m in of venous occlusion (V.O.) and plasminogen activator inhibitor type 1 (PAI-1) activity were taken at 6 months after the first episode of VTE or the first recurrent VTE in 784 and 207 patients, respectively, who were anticoagulated for 1.5 or 6 months (first VTE) and 6 months o r indefinitely (first recurrence). During a follow-up of 3-6 years fro m the event which qualified for inclusion there have been 177 recurren ces. All initial and recurrent events were verified with objective dia gnostic methods. Using cut off points of 10.0 ng/ml for t-PA antigen b efore V.O. and 30 AU/ml for PAI-1 in samples taken at rest, there were more patients above those level in the groups with than without furth er recurrence (t-PA antigen, 50% versus 36%, p = 0.001; PAI-1, 18% ver sus 12%, p = 0.045). In the 495 patients, who received oral anticoagul ation for 6 months, t-PA antigen at rest discriminated better, with 59 % versus 34% of patients above 10 ng/ml in the groups with and without recurrence, respectively (p < 0.001). The t-PA antigen levels after V .O. and the fibrinolytic capacity (t-PA antigen after V.O. minus t-PA antigen before V.O.) were distributed similarly in patients with and w ithout new; recurrences. There was a statistically significant positiv e correlation between age and t-PA antigen (p < 0.001), and by analysi s of covariance the difference between the groups with and without fur ther recurrence regarding t-PA antigen disappeared. In conclusion, inc reased levels of PAI-1 and t-PA antigen in VTE-patients correlate with development of recurrent VTE within the next 3-6 years, but the value of these components in predicting future events for the individual pa tient is limited.